Terapia Ranbaxy sales resume growth in second quarter - Azi

All news

The sales of Terapia Ranbaxy, part of the Indian Ranbaxy group, fell 14% in the first half of this year, compared with the corresponding period in 2007, and reached 57 million dollars (more than 36 million euros) as a result of the impact and reforms in the health care field on the pharmaceuticals market, according to the half-year report of the Indian group.

After having posted 29% sales decline in the first quarter of this year, to 26 million dollars (more than 16 million euros), Terapia...

Read the whole story in: Ziarul Financiar